Benjamin G. Bitler, Ph.D.
Affiliations: | 2010 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
Cell BiologyGoogle:
"Benjamin Bitler"Parents
Sign in to add mentor| Joyce A. Schroeder | grad student | 2010 | University of Arizona | |
| (Determining the role of MUC1 and beta-catenin on the epidermal growth factor receptor signaling and localization in breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Persenaire C, Babbs B, Yamamoto TM, et al. (2024) VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression. Molecular Carcinogenesis |
| Crump LS, Floyd JL, Kuo LW, et al. (2024) Targeting tryptophan catabolism in ovarian cancer to attenuate macrophage infiltration and PD-L1 expression. Cancer Research Communications. 4: 822-33 |
| Villagomez FR, Lang J, Webb P, et al. (2024) Claudin-4 modulates autophagy via SLC1A5/LAT1 as a tolerance mechanism for genomic instability in ovarian cancer. Biorxiv : the Preprint Server For Biology |
| Sottnik JL, Shackleford MT, Robinson SK, et al. (2023) WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers. Cancer Research Communications |
| Bapat J, Yamamoto TM, Woodruff ER, et al. (2023) CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR. Cancer Gene Therapy |
| Callaway CS, Mouchantat LM, Bitler BG, et al. (2023) Mechanisms of Ovarian Cancer-Associated Cachexia. Endocrinology. 165 |
| Brubaker LW, Backos DS, Nguyen VT, et al. (2023) Novel chromobox 2 inhibitory peptide decreases tumor progression. Expert Opinion On Therapeutic Targets. 1-11 |
| Corr BR, Moroney MR, Woodruff E, et al. (2023) Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in -mutated endometrial cancer. Biorxiv : the Preprint Server For Biology |
| Neville MC, Webb PG, Baumgartner HK, et al. (2022) Claudin-4 localization in epithelial ovarian cancer. Heliyon. 8: e10862 |
| Holmberg R, Robinson M, Gilbert SF, et al. (2022) TWEAK-Fn14-RelB signaling cascade promotes stem cell-like features that contribute to post-chemotherapy ovarian cancer relapse. Molecular Cancer Research : McR |